Evidence map›Paper›PMID 35411090›Full record

ArticleCancer gene therapy2022

Activated Src requires Cadherin-11, Rac, and gp130 for Stat3 activation and survival of mouse Balb/c3T3 fibroblasts.

Hanad Adan, Stephanie Guy, Rozanne Arulanandam, Mulu Geletu, Juliet Daniel, Leda Raptis

Open access · hybridAbstract read
In one paragraph

Article in Cancer gene therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Hanad AdanDepartment of Pathology and Molecular Medicine, Queen's University, Kingston, ON, K7L 3N6, Canada.ORCID http://orcid.org/0000-0002-9476-134X
Stephanie GuyOttawa Hospital Research Institute, University of Ottawa, Ottawa, ON, K1N 6N5, Canada.
Rozanne ArulanandamOttawa Hospital Research Institute, University of Ottawa, Ottawa, ON, K1N 6N5, Canada.ORCID http://orcid.org/0000-0002-4750-499X
Mulu GeletuDepartment of Chemistry, University of Toronto, Mississauga, ON, L5L 1C6, Canada.
Juliet DanielDepartment of Biology, McMaster University, Hamilton, ON, L8S 4L8, Canada.
Leda RaptisDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, K7L 3N6, Canada. raptisl@queensu.ca.ORCID http://orcid.org/0000-0002-6517-4429
Queen's University · CAUniversity of Ottawa · CAMcMaster University · CAUniversity of Toronto · CA

Funding

CIHR
6 · The paper itself

Abstract

We previously demonstrated that engagement of cadherins, cell to cell adhesion molecules, triggers a dramatic increase in levels and activity of the Rac/Cdc42 small GTPases, which is followed by secretion of IL6 family cytokines and activation of their common receptor, gp130, in an autocrine manner. This results in phosphorylation of the Signal Transducer and Activator of Transcription-3 (Stat3) on tyrosine-705, which then dimerizes, migrates to the nucleus, and activates transcription of genes involved in cell division and survival. In the present report we demonstrate that, in mouse Balb/c3T3 fibroblasts, mutationally activated Src

Indexed as

Interleukin-6STAT3 Transcription FactorAnimalsCadherinsCytokine Receptor gp130CytokinesFibroblastsGenes, srcMicePhosphorylationrac GTP-Binding ProteinsTyrosineCadherinsCytokine Receptor gp130CytokinesInterleukin-6osteoblast cadherinrac GTP-Binding ProteinsSTAT3 Transcription FactorTyrosine

Identifiers

PMID35411090
PMCPMC9576600
OpenAlexW4223494201

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.